Cargando…
ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells
Management of infection with hepatitis B virus (HBV) remains a global health problem. Persistence of stable covalently closed circular DNA (cccDNA) during HBV replication is responsible for modest curative efficacy of currently licensed drugs. Novel gene editing technologies, such as those based on...
Autores principales: | Scott, Tristan, Moyo, Buhle, Nicholson, Samantha, Maepa, Mohube Betty, Watashi, Koichi, Ely, Abdullah, Weinberg, Marc S., Arbuthnot, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547162/ https://www.ncbi.nlm.nih.gov/pubmed/28785016 http://dx.doi.org/10.1038/s41598-017-07642-6 |
Ejemplares similares
-
Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs
por: Maepa, Mohube Betty, et al.
Publicado: (2017) -
Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
por: Bloom, Kristie, et al.
Publicado: (2018) -
Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
por: Ely, Abdullah, et al.
Publicado: (2021) -
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
por: van den Berg, Fiona, et al.
Publicado: (2020) -
In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors
por: Limani, Shonisani Wendy, et al.
Publicado: (2021)